会員登録
ログイン
【4892】サイフューズ
バイオ 3D プリンタを用いた、再生医療等製品の開発・製造・販売
類似企業：
【業界1位】
武田薬品工業
【業界1位】
武田薬品工業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026.12 | 2026/08/14 | Q2予 | 278 | → | 0.0% | 0.0% | -1,081 | → | 0.0% | 0.0% | -1,056 | → | 0.0% | 0.0% | -1,059 | → | 0.0% | 0.0% |
| 2026.12 | 2026/05/15 | Q1予 | 278 | → | 0.0% | 0.0% | -1,081 | → | 0.0% | 0.0% | -1,056 | → | 0.0% | 0.0% | -1,059 | → | 0.0% | 0.0% |
| 2026.12 | 2026/02/13 | 当初予 | 278 | - | - | - | -1,081 | - | - | - | -1,056 | - | - | - | -1,059 | - | - | - |
| 2025.12 | 2026/02/13 | 実 | 230 | → | 0.0% | -23.8% | -828 | → | 0.0% | +32.1% | -761 | → | 0.0% | +33.2% | -763 | → | 0.0% | +33.2% |
| 2025.12 | 2026/01/22 | 修正予 | 230 | ↓ | -23.8% | -23.8% | -828 | ↑ | +32.1% | +32.1% | -761 | ↑ | +33.2% | +33.2% | -763 | ↑ | +33.2% | +33.2% |
| 2025.12 | 2025/11/14 | Q3予 | 302 | → | 0.0% | 0.0% | -1,219 | → | 0.0% | 0.0% | -1,140 | → | 0.0% | 0.0% | -1,142 | → | 0.0% | 0.0% |
| 2025.12 | 2025/08/14 | Q2予 | 302 | → | 0.0% | 0.0% | -1,219 | → | 0.0% | 0.0% | -1,140 | → | 0.0% | 0.0% | -1,142 | → | 0.0% | 0.0% |
| 2025.12 | 2025/05/15 | Q1予 | 302 | → | 0.0% | 0.0% | -1,219 | → | 0.0% | 0.0% | -1,140 | → | 0.0% | 0.0% | -1,142 | → | 0.0% | 0.0% |
| 2025.12 | 2025/02/14 | 当初予 | 302 | - | - | - | -1,219 | - | - | - | -1,140 | - | - | - | -1,142 | - | - | - |
| 2024.12 | 2025/02/14 | 実 | 54 | ↓ | -10.0% | -91.1% | -896 | ↑ | +3.2% | -12.4% | -869 | ↑ | +3.6% | -20.0% | -872 | ↑ | +3.5% | -19.9% |
| 2024.12 | 2024/11/14 | Q3予 | 60 | ↓ | -90.1% | -90.1% | -926 | ↓ | -16.2% | -16.2% | -901 | ↓ | -24.4% | -24.4% | -904 | ↓ | -24.3% | -24.3% |
| 2024.12 | 2024/08/14 | Q2予 | 605 | → | 0.0% | 0.0% | -797 | → | 0.0% | 0.0% | -724 | → | 0.0% | 0.0% | -727 | → | 0.0% | 0.0% |
| 2024.12 | 2024/05/15 | Q1予 | 605 | → | 0.0% | 0.0% | -797 | → | 0.0% | 0.0% | -724 | → | 0.0% | 0.0% | -727 | → | 0.0% | 0.0% |
| 2024.12 | 2024/02/14 | 当初予 | 605 | - | - | - | -797 | - | - | - | -724 | - | - | - | -727 | - | - | - |
| 2023.12 | 2024/02/14 | 実 | 61 | → | 0.0% | -89.9% | -697 | ↓ | -0.1% | +16.3% | -586 | ↓ | -0.3% | +13.8% | -589 | ↓ | -0.3% | +13.6% |
| 2023.12 | 2024/01/25 | 修正予 | 61 | ↑ | +19.6% | -89.9% | -696 | ↑ | +11.1% | +16.4% | -584 | ↑ | +13.1% | +14.1% | -587 | ↑ | +13.0% | +13.9% |
| 2023.12 | 2023/11/14 | Q3予 | 51 | ↓ | -91.6% | -91.6% | -783 | ↑ | +6.0% | +6.0% | -672 | ↑ | +1.2% | +1.2% | -675 | ↑ | +1.0% | +1.0% |
| 2023.12 | 2023/08/14 | Q2予 | 604 | → | 0.0% | 0.0% | -833 | → | 0.0% | 0.0% | -680 | → | 0.0% | 0.0% | -682 | → | 0.0% | 0.0% |
| 2023.12 | 2023/05/15 | Q1予 | 604 | → | 0.0% | 0.0% | -833 | → | 0.0% | 0.0% | -680 | → | 0.0% | 0.0% | -682 | → | 0.0% | 0.0% |
| 2023.12 | 2023/02/14 | 当初予 | 604 | - | - | - | -833 | - | - | - | -680 | - | - | - | -682 | - | - | - |
| 2022.12 | 2023/02/14 | 実 | 374 | - | - | - | -425 | - | - | - | -433 | - | - | - | -473 | - | - | - |
